Obstetrics & Gynecology · Roseville, CA
NPI
1376615187
Since 2006
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1600 Eureka Rd
Roseville, CA, 95661
Phone (916) 784-4000
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$62K
729 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Deanna E Mullin prescribed most often to Medicare patients was Yuvafem (Estradiol), with 142 prescriptions and refills. In total Deanna E Mullin wrote 729 Medicare prescriptions that cost $62K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Yuvafem Estradiol | 142 | 354 | 57 | $17K |
| Estradiol Generic | 106 | 370 | 63 | $4,429 |
| Clobetasol Propionate Generic | 52 | 52 | 35 | $1,089 |
| Trospium Chloride Generic | 41 | 136 | 17 | $2,142 |
| Estring Estradiol | 36 | 108 | 13 | $22K |
| Progesterone Progesterone, Micronized | 26 | 87 | 11 | $1,378 |
| Fluconazole Generic | 23 | 33 | 18 | $166 |
| Alendronate Sodium Generic | 23 | 64 | Under 11 | $225 |
| Climara Estradiol | 22 | 61 | Under 11 | $3,077 |
| Metronidazole Generic | 20 | 20 | 19 | $267 |
| Vandazole Metronidazole | 18 | 20 | Under 11 | $1,296 |
| Triamcinolone Acetonide Generic | 17 | 17 | 13 | $241 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 16 | 18 | Under 11 | $756 |
| Ciprofloxacin Hcl Generic | 15 | 15 | 12 | $99.82 |
| Nystatin-Triamcinolone Nystatin/Triamcinolone Acet | 15 | 15 | Under 11 | $821 |
Brand drugs: 86 claims; generic drugs: 643 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Deanna E Mullin were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.